These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2198580)

  • 1. Fusion of human immunodeficiency virus type 1 (HIV-1) with human cells as measured by membrane fluorescence dequenching (DQ) method; roles of HIV-1-cell fusion in AIDS pathogenesis.
    Volsky DJ
    Prog Clin Biol Res; 1990; 343():179-98. PubMed ID: 2198580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research advances on fusion peptide and mechanisms about virus penetration into membrane].
    Wu M; Nie SQ
    Sheng Li Ke Xue Jin Zhan; 1998 Jul; 29(3):221-5. PubMed ID: 12501639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
    Azevedo-Pereira JM; Santos-Costa Q
    Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion.
    Tardieu M; Héry C; Peudenier S; Boespflug O; Montagnier L
    Ann Neurol; 1992 Jul; 32(1):11-7. PubMed ID: 1303631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK.
    De Mareuil J; Salaun D; Chermann JC; Hirsch I
    Virology; 1995 Jun; 209(2):649-53. PubMed ID: 7778297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural biology of type I viral membrane fusion.
    Colman PM; Lawrence MC
    Nat Rev Mol Cell Biol; 2003 Apr; 4(4):309-19. PubMed ID: 12671653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).
    Broder CC; Dimitrov DS; Blumenthal R; Berger EA
    Virology; 1993 Mar; 193(1):483-91. PubMed ID: 8438583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching.
    Sinangil F; Loyter A; Volsky DJ
    FEBS Lett; 1988 Oct; 239(1):88-92. PubMed ID: 2846352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron microscopic analysis of HIV-host cell interactions.
    Pudney J; Song MJ
    Tissue Cell; 1994 Aug; 26(4):539-50. PubMed ID: 8091422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenic mechanisms of HIV infection.
    Rosenberg ZF; Fauci AS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S149-56. PubMed ID: 2562941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between binding, phagocytosis and membrane fusion of enveloped viruses.
    Haywood AM
    Prog Clin Biol Res; 1990; 343():117-32. PubMed ID: 2198578
    [No Abstract]   [Full Text] [Related]  

  • 17. [Entry process of enveloped viruses to host cells].
    Miyauchi K
    Uirusu; 2009 Dec; 59(2):205-13. PubMed ID: 20218329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enveloped viruses: a common mode of membrane fusion?
    Hughson FM
    Curr Biol; 1997 Sep; 7(9):R565-9. PubMed ID: 9285698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic entry of enveloped viruses: fusion versus endocytosis.
    Chou T
    Biophys J; 2007 Aug; 93(4):1116-23. PubMed ID: 17513379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane fusion of enveloped viruses: especially a matter of proteins.
    Hoekstra D
    J Bioenerg Biomembr; 1990 Apr; 22(2):121-55. PubMed ID: 2109749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.